Hiromichi Shirasu

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer

Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura et al. · Nature Medicine · 2023 · 430 citations · Full text

Surgical Oncology, Oncology, Cancer Epidemiology +15

CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer

Hiroya Taniguchi, Yoshiaki Nakamura, Daisuke Kotani et al. · Cancer Science · 2021 · 135 citations · Full text

Association of circulating tumor DNA dynamics with clinical outcomes in the adjuvant setting for patients with colorectal cancer from an observational GALAXY study in CIRCULATE-Japan.

Masahito Kotaka, Hiromichi Shirasu, Jun Watanabe et al. · Journal of Clinical Oncology · 2022 · 61 citations

Surgical Oncology, Cancer Management, Adjuvant Chemotherapy +18

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study

Takeshi Kawakami, Takahiro Tsushima, Katsuhiro Omae et al. · BMC Cancer · 2018 · 58 citations · Full text

The Prognostic Impact of <i>KRAS</i> G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study

Keigo Chida, Daisuke Kotani, Toshiki Masuishi et al. · The Oncologist · 2021 · 50 citations · Full text